Dicot Pharma AB (STO:DICOT)

Dicot Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	105.8	113.42	47.34	9.38	30.33	20.33
Cash & Short-Term Investments	105.8	113.42	47.34	9.38	30.33	20.33
Cash Growth	518.57%	139.58%	404.88%	-69.08%	49.20%	66.30%
Other Receivables	6	3.47	2.3	1.14	1.01	0.9
Receivables	6	3.47	2.3	1.14	1.01	0.9
Inventory	6.5	5.38	3.4	1.49	-	-
Prepaid Expenses	-	1.35	0.5	0.34	0.4	0.34
Other Current Assets	-	-	-0	-	-	-
Total Current Assets	118.3	123.62	53.54	12.35	31.74	21.57
Property, Plant & Equipment	-	-	0.01	0.02	0.03	0.04
Total Assets	118.3	123.62	53.56	12.37	31.77	21.61
Accounts Payable	-	6.84	4.54	3.42	2.58	1.49
Accrued Expenses	-	4.05	3.98	1.19	0.66	0.37
Other Current Liabilities	12	1.07	0.64	2.41	0.19	0.09
Total Current Liabilities	12	11.96	9.16	7.01	3.42	1.95
Total Liabilities	12	11.96	9.16	7.01	3.42	1.95
Common Stock	14.1	12.45	5.72	17.14	12.86	5.46
Additional Paid-In Capital	-	299	180.76	86.15	81.67	53.2
Retained Earnings	-	-199.79	-142.09	-97.93	-66.18	-39
Comprehensive Income & Other	92.2	-	-	-	-	-
Shareholders' Equity	106.3	111.67	44.39	5.36	28.35	19.66
Total Liabilities & Equity	118.3	123.62	53.56	12.37	31.77	21.61
Net Cash (Debt)	105.8	113.42	47.34	9.38	30.33	20.33
Net Cash Growth	518.57%	139.58%	404.88%	-69.08%	49.20%	66.30%
Net Cash Per Share	0.07	0.10	0.09	0.08	0.47	0.71
Filing Date Shares Outstanding	2,009	1,779	817.56	137.1	102.9	43.67
Total Common Shares Outstanding	2,009	1,779	817.56	137.1	102.9	43.67
Working Capital	106.3	111.67	44.38	5.34	28.32	19.62
Book Value Per Share	0.05	0.06	0.05	0.04	0.28	0.45
Tangible Book Value	106.3	111.67	44.39	5.36	28.35	19.66
Tangible Book Value Per Share	0.05	0.06	0.05	0.04	0.28	0.45
Machinery	-	-	0.04	0.04	0.04	0.04

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.